OPKO Health stock triggers USD 121 million note conversions

Published on 10/04/2026 at 10:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

OPKO Health stock closed at USD 1.56 on October 2, 2026, down 0.64 percent from the prior close. Q2 revenue reached USD 163.58 million, up 4.3 percent year over year.

OPK, US68375N1037, Illustration mit AI erstellt.

OPKO Health (US68375N1037) closed at USD 1.56 on Nasdaq on October 2, 2026, down 0.64 percent from the prior close. The company has opened a conversion window for USD 121 million of notes, giving the latest stock level a direct capital-markets consequence.

Convertible notes reach conversion window

According to StockTitan, OPKO determined on October 1, 2026 that holders of its 3.75 percent convertible senior notes due 2029 may convert through December 31, 2026. The company plans to satisfy the conversion obligation with common stock.

The trigger required OPK to close above USD 1.495 for at least 20 of 30 consecutive trading days during the quarter ended September 30, 2026. Each USD 1,000 principal amount converted represents 869.5652 common shares before any additional shares under the early-conversion provisions.

Revenue improves while losses persist

MarketBeat reported that OPKO's Q2 2026 revenue reached USD 163.58 million, up 4.3 percent from the same quarter a year earlier. Adjusted loss per share was USD 0.01 against a consensus loss of USD 0.08, a USD 0.07 improvement versus expectations.

The standardized Q2 2026 financial data show a GAAP net loss of USD 8.42 million and an operating loss of USD 6.97 million for the quarter ended June 30, 2026. Revenue growth therefore came with continuing losses, making the potential share issuance an important counterweight to the operating improvement.

Consensus stays near the stock price

According to MarketBeat on October 3, 2026, six brokerages held a consensus Hold rating, with one sell, three hold, one buy and one strong-buy rating. The average 12-month price target was USD 1.55, below the October 2 closing price by USD 0.01.

OPK traded between USD 1.550 and USD 1.580 during the October 2 session, while its 52-week range ran from USD 0.977 to USD 1.750. The stock's market capitalization was USD 1.2 billion and volume was 1,398,968 shares.

Stock stays below yearly high

OPKO Health closed at USD 1.56 on Nasdaq on October 2, 2026, with a 52-week high of USD 1.750 and a 52-week low of USD 0.977. The conversion event and the Q2 revenue comparison now frame the stock's near-term valuation discussion.